124 related articles for article (PubMed ID: 37008273)
1. Erratum to "E.C. Lerner, E.S. Srinivasan, G. Broadwater, et al. Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases.
Lerner EC; Srinivasan ES; Broadwater G; Haskell-Mendoza AP; Vaios EJ; Edwards RM; Wachsmuth LP; Huie D; Floyd SR; Adamson JD; Fecci PE
Adv Radiat Oncol; 2023; 8(2):101187. PubMed ID: 37008273
[TBL] [Abstract][Full Text] [Related]
2. Erratum to "C. Hehakaya, A.M. Sharma, J.R.N. van der Voort Van Zijp, et al. Implementation of Magnetic Resonance Imaging-Guided Radiation Therapy in Routine Care: Opportunities and Challenges in the United States.
Adv Radiat Oncol; 2022; 7(5):101049. PubMed ID: 36148371
[TBL] [Abstract][Full Text] [Related]
3. Erratum to: Young S, Phaterpekar K, Tsang DS, Boldt G, Bauman GS. Proton Radiotherapy for Management of Medulloblastoma: A Systematic Review of Clinical Outcomes.
Adv Radiat Oncol; 2023; 8(4):101232. PubMed ID: 37465005
[TBL] [Abstract][Full Text] [Related]
4. Erratum to: Miller RC and Tsai CJ. ASTRO's
Adv Radiat Oncol; 2023; 8(4):101278. PubMed ID: 37465004
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery for vestibular schwannomas: in regard to Kapoor et al. (Int J Radiat Oncol Biol Phys 2011;81:647-653).
Roos DE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1324. PubMed ID: 22385724
[No Abstract] [Full Text] [Related]
6. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer: in regard to Unger et al. (Int J Radiat Oncol Biol Phys 2010;77:1411-1419).
Rwigema JC; Heron DE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1323; author reply 1323-4. PubMed ID: 22385722
[No Abstract] [Full Text] [Related]
7. Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271).
Kavanagh BD; Newman F
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):958-9. PubMed ID: 18514788
[No Abstract] [Full Text] [Related]
8. Chasing your dural tail: Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas: In regard to DiBiase et al. (Int J Radiat Oncol Biol Phys 2004;60:1515-1519).
Rogers L; Jensen R; Perry A
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):616-8; author reply 618-9. PubMed ID: 15890610
[No Abstract] [Full Text] [Related]
9. Erratum to: Sperduto PW, Mesko S, Li J, et al. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today. Int J Radiat Oncol Biol Phys 2020:107(2);334-343.
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):303. PubMed ID: 33308700
[No Abstract] [Full Text] [Related]
10. Tumor relapse or radionecrosis after radiosurgery: single-photon emission computed tomography for differential diagnosis. In regard to Blonigen et al. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. (Int J Radiat Oncol Biol Phys 2010;77:996-1001).
Maranzano E; Trippa F; Loreti F
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1279. PubMed ID: 20970034
[No Abstract] [Full Text] [Related]
11. In reply to Furweger et al. (Int J Radiat Oncol Biol Phys DOI: 10.1016/j.ijrobp.2009.11.030).
Ma L; Sahgal A; Larson D
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1324; author reply 1324. PubMed ID: 22385727
[No Abstract] [Full Text] [Related]
12. Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
Vordermark D; Kölbl O
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):296-7; author reply 297. PubMed ID: 15850943
[No Abstract] [Full Text] [Related]
13. Toward a unified survival curve: in regard to Kavanagh and Newman (Int J Radiat Oncol Biol Phys 2008;71:958-959) and Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852).
McKenna F; Ahmad S
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):640; author reply 640-1. PubMed ID: 19147035
[No Abstract] [Full Text] [Related]
14. Erratum to: Sanders JW, Venkatesan AM, Levitt CA, et al. Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study. Int J Radiat Oncol Biol Phys 2021;109(2):614-625.
Int J Radiat Oncol Biol Phys; 2022 May; 113(1):238. PubMed ID: 35427557
[No Abstract] [Full Text] [Related]
15. Reporting of true spinal cord dose is encouraged for stereotactic body radiation therapy for spinal tumors. In regard to Sahgal et al. (Int J Radiat Oncol Biol Phys 2010;77:548-553).
Lo SS; Wang JZ; Radawski JD; Mayr NA
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):314; author reply 314. PubMed ID: 20708487
[No Abstract] [Full Text] [Related]
16. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses: in regard to Milano et al. (Int J Radiat Oncol Biol Phys 2009;73:832-837).
Christodouleas JP; Marks LB
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1628; author reply 1628-9. PubMed ID: 19616752
[No Abstract] [Full Text] [Related]
17. Response to "Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo." (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and "Influence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): response to Drs. Mayer and Timmerman." (Int J Radiation Oncol Biol Phys 2011;78:1600).
Song CW; Levitt SH; Park H
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1193; author reply 1193-4. PubMed ID: 22036162
[No Abstract] [Full Text] [Related]
18. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to Register et al. Int J Radiat Oncol Biol Phys 2011;80:1015-1022.
Bongers EM; Dahele MR; Slotman BJ; Senan S; Bot JC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):492; author reply 492. PubMed ID: 22182718
[No Abstract] [Full Text] [Related]
19. Erratum to: Kong X-T, Nguyen NT, Choi YJ, et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys 2018;100:1195-1203.
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1289. PubMed ID: 30900570
[No Abstract] [Full Text] [Related]
20. In regard to Sperduto et al. (Int j radiat oncol biol phys 2008;70:510-514).
Weltman E; Brandt RA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1292; author reply 1292-3. PubMed ID: 18313534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
